Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Tagitanlimab Injection

Approval Number

国药准字S20240058

Company四川科伦博泰生物医药股份有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

塔戈利单抗注射液

Trade Name

科泰莱

Dosage Form

注射剂

Strength

200mg（10ml）/瓶

Drug Type

生物制品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name四川科伦博泰生物医药股份有限公司

Company Address

四川省成都市温江区成都海峡两岸科技产业开发园区新华大道666号

Manufacturing Company

Company Name四川科伦博泰生物医药股份有限公司

Company Address

成都市温江区成都海峡两岸科技产业开发园区新华大道666号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy